Patent ID: 8304452

Claim:
A method of and treating at least one disease or condition selected from the group consisting of cataracts; damage to the eye following ophthalmologic surgery; damage to the eye from contact lenses; damage following a corneal transplantation; open-angle glaucoma, corneal disease; dry eye; bleary eye; macular degeneration; age-related macular degeneration; retinopathy of prematurity; eye siderosis; and uveal disease in a subject in need thereof, the method comprising administering an effective amount of an opthalmically suitable composition comprising a 3,4-hydrophenylalanine compound of formula (I) to the eye of the subject: wherein R 1 represents hydrogen atom or an a-amino acid, a β-amino acid, or a γy-amino acid bound via an amide bond; R 2 represents hydrogen atom or a group represented by the following formula (II): wherein R 3 represents an α-amino acid, a β-amino acid, or a γ-amino acid; R 4 represents hydroxyl group an α-amino acid, a β-amino acid, or a γ-amino acid; and n represents 1 or 2; wherein if either R 1 or R 2 is hydrogen atom, the other is not a hydrogen atom, or a pharmaceutically acceptable salt thereof.